Levi Strauss & Co. vs McKesson Corporation — how do they compare? Levi Strauss & Co. trades at $22.73 (market cap $8.75B), while McKesson Corporation trades at $895.01 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 12× Levi Strauss & Co.'s market cap, and Levi Strauss & Co. pays the higher dividend (2.81%). Which is the better fit depends on your goals.
| LEVI | MCK | |
|---|---|---|
Market Cap | $8.75B | $105.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $25.53 | $995.69 |
52-Week Low | $17.92 | $659.01 |
Enterprise Value | $10.07B | $111.67B |
Dividend Yield | 2.81% | 0.42% |
Trailing returns across standard periods
Latest headlines on both assets
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver
Read more on LEVI →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →